Restor3d has agreed to pay approximately $17m to acquire Conformis, its competitor in the 3D-printed orthopedics market.
It will purchase all outstanding common stock shares of Conformis at a price of $2.27 each
The two companies will merge following a cash-for-shares offer from restore3d being accepted by Conformis’ board.
Restor3d has agreed to pay approximately $17m to acquire Conformis, its competitor in the 3D-printed orthopedics market.
It will purchase all outstanding common stock shares of Conformis at a price of $2.27 each